U.S. Markets
Twenty people in Japan who took an Amgen (AMGN) rare immune-disease drug have died, according to the company that sells the Medicine in Japan; US drug regulators had asked Amgen to voluntarily withdraw the drug
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
